Drug
Unesbulin
Unesbulin: highest development phase Phase 2/3, developed by PTC Therapeutics. 3 trial records tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- PTC Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Unesbulin NCT05269355 | Phase 2/3 | Leiomyosarcoma |
| Unesbulin NCT03761095 | Phase 1 | Leiomyosarcoma |
| Unesbulin NCT03206645 | Phase 1 | Ovarian Cancer |
Latest
Follow Unesbulin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.